[SCHEDULE 13D/A] Bausch Health Companies Inc SEC Filing
Paulson & Co. Inc. reports beneficial ownership of 70,755,869 common shares of Bausch Health Companies Inc., representing approximately 19.1% of the outstanding common shares based on 369,790,319 shares disclosed by the issuer. The stake is held through funds advised or managed by Paulson, which retain sole voting and dispositive power over these shares for reporting purposes, while Paulson disclaims direct pecuniary ownership except through those funds. The filing notes recent transactions are listed in an attached exhibit and identifies the issuer's principal executive office in Laval, Quebec. This amendment updates prior Schedule 13D disclosures and clarifies the reporting person鈥檚 role as investment manager.
Paulson & Co. Inc. dichiara la propriet脿 beneficiaria di 70.755.869 azioni ordinarie di Bausch Health Companies Inc., pari a circa 19,1% delle azioni ordinarie in circolazione, sulla base delle 369.790.319 azioni comunicate dall'emittente. La posizione 猫 detenuta tramite fondi consigliati o gestiti da Paulson, che per finalit脿 di segnalazione mantengono il potere esclusivo di voto e di disposizione su tali azioni; Paulson dichiara di non possedere direttamente l鈥檌nteresse pecuniario se non attraverso detti fondi. Il deposito indica che le transazioni recenti sono elencate in un allegato e individua l'ufficio principale dell'emittente a Laval, Qu茅bec. Questa modifica aggiorna le precedenti comunicazioni ai sensi del Modulo 13D e precisa il ruolo della parte segnalante come gestore degli investimenti.
Paulson & Co. Inc. informa de la propiedad beneficiaria de 70.755.869 acciones ordinarias de Bausch Health Companies Inc., lo que representa aproximadamente el 19,1% de las acciones ordinarias en circulaci贸n, seg煤n las 369.790.319 acciones divulgadas por el emisor. La participaci贸n se detiene a trav茅s de fondos asesorados o gestionados por Paulson, que mantienen el poder exclusivo de voto y disposici贸n sobre estas acciones a efectos de notificaci贸n; Paulson niega la propiedad pecuniaria directa salvo a trav茅s de dichos fondos. El formulario se帽ala que las transacciones recientes figuran en un anexo y localiza la oficina principal del emisor en Laval, Quebec. Esta enmienda actualiza divulgaciones previas del Schedule 13D y aclara el papel del informante como gestor de inversiones.
Paulson & Co. Inc.電� Bausch Health Companies Inc.鞚� 氤错喌欤� 70,755,869欤茧ゼ 鞁れ鞝� 靻岇湢甓岇溂搿� 氤搓碃頃橂┌, 鞚措姅 氚滍枆鞚胳澊 瓿奠嫓頃� 369,790,319欤茧ゼ 旮办鞙茧 鞎� 19.1%鞐� 頃措嫻頃╇媹雼�. 鞚� 歆�攵勳潃 Paulson鞚� 鞛愲頃橁卑雮� 鞖挫毄頃橂姅 韼�霌滊ゼ 韱淀暣 氤挫湢霅橁碃 鞛堨溂氅�, 氤搓碃 氇╈爜靸� 頃措嫻 欤检嫕鞐� 雽�頃� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 Paulson鞚� 鞙犾頃╇媹雼�. Paulson鞚� 頃措嫻 韼�霌滊ゼ 韱淀暅 瓴届毎毳� 鞝滌櫢頃橁碃 歆侅爲鞝侅澑 旮堨爠鞝� 靻岇湢甓岇潃 攵�鞚疙暕雼堧嫟. 鞝滌稖靹滊電� 斓滉芳 瓯半灅霌れ澊 觳秬 鞝勳嫓氍检棎 旮办灛霅橃柎 鞛堨潓鞚� 氚濏瀳瓿� 氚滍枆鞚胳潣 氤胳偓 靻岇灛歆�毳� 旌愲倶雼� 韤橂病欤� 霛茧皽搿� 氇呾嫓頃╇媹雼�. 鞚� 靾橃爼靹滊姅 鞚挫爠鞚� Schedule 13D 瓿奠嫓毳� 臧膘嫚頃橁碃 氤搓碃鞚胳潣 韴瀽鞖挫毄鞛�(韴瀽 毵る媹鞝�) 鞐暊鞚� 氇呿檿頌� 頃╇媹雼�.
Paulson & Co. Inc. d茅clare la propri茅t茅 b茅n茅ficiaire de 70 755 869 actions ordinaires de Bausch Health Companies Inc., repr茅sentant environ 19,1% des actions ordinaires en circulation, sur la base des 369 790 319 actions divulgu茅es par l'茅metteur. La participation est d茅tenue via des fonds conseill茅s ou g茅r茅s par Paulson, qui conservent, aux fins du rapport, le pouvoir exclusif de vote et de disposition sur ces actions ; Paulson d茅cline toute propri茅t茅 p茅cuniaire directe sauf par l'interm茅diaire de ces fonds. Le d茅p么t indique que les transactions r茅centes figurent dans une annexe et identifie le si猫ge social de l'茅metteur 脿 Laval, Qu茅bec. Cet amendement met 脿 jour les divulgations ant茅rieures au titre du Schedule 13D et pr茅cise le r么le de la personne d茅clarante en tant que gestionnaire d'investissement.
Paulson & Co. Inc. meldet die wirtschaftliche Inhaberschaft an 70.755.869 Stammaktien der Bausch Health Companies Inc., was etwa 19,1% der ausstehenden Stammaktien entspricht, basierend auf 369.790.319 vom Emittenten offengelegten Aktien. Die Beteiligung wird 眉ber von Paulson beratenen oder verwalteten Fonds gehalten, wobei Paulson f眉r Berichtszwecke das alleinige Stimm- und Verf眉gungsrecht 眉ber diese Aktien innehat; direkte wirtschaftliche Eigentumsrechte werden von Paulson au脽er in Bezug auf diese Fonds bestritten. Die Meldung verweist auf ein beigef眉gtes Exponat mit den j眉ngsten Transaktionen und nennt den Sitz des Emittenten in Laval, Quebec. Diese 脛nderung aktualisiert fr眉here Schedule-13D-Angaben und stellt den Berichtenden als Investmentmanager klar.
- Significant disclosed stake: Reporting person holds 70,755,869 shares, ~19.1% of outstanding common shares, indicating material ownership
- Clear voting authority: Paulson reports sole voting and dispositive power over the reported shares for governance clarity
- Transparency via amendment: This Schedule 13D/A updates prior disclosures and references transaction details in an exhibit
- None.
Insights
TL;DR A large, disclosed 19.1% stake by an activist-style investor is material and could affect governance or strategic outcomes.
Paulson's reported 19.1% position in Bausch Health is a substantial ownership level that may influence voting outcomes and corporate decisions, especially given Paulson's sole voting and dispositive power over the shares reported. The position is held through advisory vehicles, consistent with standard asset-manager reporting where the firm disclaims direct pecuniary ownership. The filing references transaction detail in an exhibit, which investors should review to understand how the position changed recently.
TL;DR Disclosure of near-20% ownership is material to board dynamics and shareholder negotiations.
Holding roughly one-fifth of the outstanding common shares grants the reporting person meaningful influence in governance matters. The statement that Paulson has sole voting power over the reported shares clarifies decision-making authority for those securities. The filing is an amendment to prior Schedule 13D disclosures and points to attached exhibits for recent transactions, which will show whether the position was accumulated recently or adjusted over time.
Paulson & Co. Inc. dichiara la propriet脿 beneficiaria di 70.755.869 azioni ordinarie di Bausch Health Companies Inc., pari a circa 19,1% delle azioni ordinarie in circolazione, sulla base delle 369.790.319 azioni comunicate dall'emittente. La posizione 猫 detenuta tramite fondi consigliati o gestiti da Paulson, che per finalit脿 di segnalazione mantengono il potere esclusivo di voto e di disposizione su tali azioni; Paulson dichiara di non possedere direttamente l鈥檌nteresse pecuniario se non attraverso detti fondi. Il deposito indica che le transazioni recenti sono elencate in un allegato e individua l'ufficio principale dell'emittente a Laval, Qu茅bec. Questa modifica aggiorna le precedenti comunicazioni ai sensi del Modulo 13D e precisa il ruolo della parte segnalante come gestore degli investimenti.
Paulson & Co. Inc. informa de la propiedad beneficiaria de 70.755.869 acciones ordinarias de Bausch Health Companies Inc., lo que representa aproximadamente el 19,1% de las acciones ordinarias en circulaci贸n, seg煤n las 369.790.319 acciones divulgadas por el emisor. La participaci贸n se detiene a trav茅s de fondos asesorados o gestionados por Paulson, que mantienen el poder exclusivo de voto y disposici贸n sobre estas acciones a efectos de notificaci贸n; Paulson niega la propiedad pecuniaria directa salvo a trav茅s de dichos fondos. El formulario se帽ala que las transacciones recientes figuran en un anexo y localiza la oficina principal del emisor en Laval, Quebec. Esta enmienda actualiza divulgaciones previas del Schedule 13D y aclara el papel del informante como gestor de inversiones.
Paulson & Co. Inc.電� Bausch Health Companies Inc.鞚� 氤错喌欤� 70,755,869欤茧ゼ 鞁れ鞝� 靻岇湢甓岇溂搿� 氤搓碃頃橂┌, 鞚措姅 氚滍枆鞚胳澊 瓿奠嫓頃� 369,790,319欤茧ゼ 旮办鞙茧 鞎� 19.1%鞐� 頃措嫻頃╇媹雼�. 鞚� 歆�攵勳潃 Paulson鞚� 鞛愲頃橁卑雮� 鞖挫毄頃橂姅 韼�霌滊ゼ 韱淀暣 氤挫湢霅橁碃 鞛堨溂氅�, 氤搓碃 氇╈爜靸� 頃措嫻 欤检嫕鞐� 雽�頃� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 Paulson鞚� 鞙犾頃╇媹雼�. Paulson鞚� 頃措嫻 韼�霌滊ゼ 韱淀暅 瓴届毎毳� 鞝滌櫢頃橁碃 歆侅爲鞝侅澑 旮堨爠鞝� 靻岇湢甓岇潃 攵�鞚疙暕雼堧嫟. 鞝滌稖靹滊電� 斓滉芳 瓯半灅霌れ澊 觳秬 鞝勳嫓氍检棎 旮办灛霅橃柎 鞛堨潓鞚� 氚濏瀳瓿� 氚滍枆鞚胳潣 氤胳偓 靻岇灛歆�毳� 旌愲倶雼� 韤橂病欤� 霛茧皽搿� 氇呾嫓頃╇媹雼�. 鞚� 靾橃爼靹滊姅 鞚挫爠鞚� Schedule 13D 瓿奠嫓毳� 臧膘嫚頃橁碃 氤搓碃鞚胳潣 韴瀽鞖挫毄鞛�(韴瀽 毵る媹鞝�) 鞐暊鞚� 氇呿檿頌� 頃╇媹雼�.
Paulson & Co. Inc. d茅clare la propri茅t茅 b茅n茅ficiaire de 70 755 869 actions ordinaires de Bausch Health Companies Inc., repr茅sentant environ 19,1% des actions ordinaires en circulation, sur la base des 369 790 319 actions divulgu茅es par l'茅metteur. La participation est d茅tenue via des fonds conseill茅s ou g茅r茅s par Paulson, qui conservent, aux fins du rapport, le pouvoir exclusif de vote et de disposition sur ces actions ; Paulson d茅cline toute propri茅t茅 p茅cuniaire directe sauf par l'interm茅diaire de ces fonds. Le d茅p么t indique que les transactions r茅centes figurent dans une annexe et identifie le si猫ge social de l'茅metteur 脿 Laval, Qu茅bec. Cet amendement met 脿 jour les divulgations ant茅rieures au titre du Schedule 13D et pr茅cise le r么le de la personne d茅clarante en tant que gestionnaire d'investissement.
Paulson & Co. Inc. meldet die wirtschaftliche Inhaberschaft an 70.755.869 Stammaktien der Bausch Health Companies Inc., was etwa 19,1% der ausstehenden Stammaktien entspricht, basierend auf 369.790.319 vom Emittenten offengelegten Aktien. Die Beteiligung wird 眉ber von Paulson beratenen oder verwalteten Fonds gehalten, wobei Paulson f眉r Berichtszwecke das alleinige Stimm- und Verf眉gungsrecht 眉ber diese Aktien innehat; direkte wirtschaftliche Eigentumsrechte werden von Paulson au脽er in Bezug auf diese Fonds bestritten. Die Meldung verweist auf ein beigef眉gtes Exponat mit den j眉ngsten Transaktionen und nennt den Sitz des Emittenten in Laval, Quebec. Diese 脛nderung aktualisiert fr眉here Schedule-13D-Angaben und stellt den Berichtenden als Investmentmanager klar.
FAQ
How many BHC shares does Paulson & Co. Inc. report owning?
What percentage of Bausch Health (BHC) is represented by Paulson鈥檚 stake?
Does Paulson claim direct ownership of the shares it reports on Schedule 13D/A?
What voting and disposition powers does Paulson report over the BHC shares?
Where can I find details of recent transactions affecting this position?
